GlobeNewswire 2/25/2016 Invitation to Year End 2015 Conference Call of MorphoSys AG on March 2, 2016
GlobeNewswire 2/24/2016 MorphoSys Announces Share Buy-Back Program
GlobeNewswire 2/24/2016 Ad hoc: MorphoSys Announces Share Buy-Back Program
GlobeNewswire 1/26/2016 MorphoSys Announces Clinical Milestone for Start of Bayer's Phase 2 Trial Designed to Support Regist...
GlobeNewswire 1/7/2016 MorphoSys to Present at J.P. Morgan Healthcare Conference
GlobeNewswire 12/7/2015 New Clinical Data on MorphoSys's Blood Cancer Drug Candidate MOR208 in NHL and CLL Presented at ASH ...
GlobeNewswire 12/7/2015 MorphoSys Presents Interim Safety, Pharmacokinetic and Efficacy Data for MOR202 in Multiple Myeloma ...
GlobeNewswire 11/16/2015 MorphoSys to Present at Two Upcoming Conferences
GlobeNewswire 11/5/2015 MorphoSys Announces Presentations at Upcoming American Society of Hematology Annual Meeting 2015
GlobeNewswire 11/4/2015 MorphoSys AG Reports Results for the First Nine Months of 2015
GlobeNewswire 10/30/2015 MorphoSys Announces Clinical Milestone in Hemophilia Program with Bayer HealthCare
GlobeNewswire 10/28/2015 MorphoSys to Host Q3 2015 Conference Call on November 4, 2015
GlobeNewswire 9/23/2015 MorphoSys Publishes Update on MOR202 in Multiple Myeloma at 15th International Myeloma Workshop
GlobeNewswire 9/8/2015 MorphoSys Provides an Update on its Proprietary Development Portfolio
GlobeNewswire 9/4/2015 MorphoSys to Present at Six Upcoming Conferences
GlobeNewswire 8/25/2015 MorphoSys and Immatics Biotechnologies Enter Strategic Alliance in Immuno-oncology
GlobeNewswire 8/4/2015 MorphoSys and G7 Therapeutics Sign Alliance to Develop Innovative Antibody Therapeutics
GlobeNewswire 7/30/2015 MorphoSys's Partner Heptares Initiates Proprietary Therapeutic Antibody Program against a GPCR Targe...
GlobeNewswire 7/27/2015 MorphoSys AG Reports Results for the First Six Months of 2015
GlobeNewswire 7/23/2015 MorphoSys Announces Clinical Milestone in Blood Disorders Program
GlobeNewswire 7/20/2015 MorphoSys to Host Q2 2015 Conference Call on 27 July 2015
GlobeNewswire 6/4/2015 BB Biotech: Change in TecDax
GlobeNewswire 6/1/2015 MorphoSys Presents Updated Phase 2 Clinical Results for MOR208 Monotherapy in NHL at ASCO Annual Mee...
GlobeNewswire 5/31/2015 MorphoSys Presents First Safety, Pharmacokinetic and Efficacy Data for MOR202 in Multiple Myeloma at...
GlobeNewswire 5/29/2015 MorphoSys to Present at Five Upcoming Conferences